A carregar...
Autologous Lymphapheresis for the Production of Chimeric Antigen Receptor (CAR) T Cells
BACKGROUND: Chimeric antigen receptor (CAR) T cells are a promising new immunotherapy. The first step in manufacturing is to collect autologous CD3+ lymphocytes by apheresis. Patients, however, are often leukopenic or have other disease-related complications. We evaluated the feasibility of collecti...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398918/ https://ncbi.nlm.nih.gov/pubmed/28236305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|